2016
DOI: 10.18203/2320-6012.ijrms20160032
|View full text |Cite
|
Sign up to set email alerts
|

Studying of heart diseases prevalence, distribution and cofactors in Sudanese population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
5
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 19 publications
1
5
0
Order By: Relevance
“…Our study shared similarities with previous Sudanese studies with regard to the mean age of HF patients, and that diabetes and hypertension were the main comorbid disease in HF [17,18]. On the other hands, 77% of patients were on Beta blockers, and 55.5% on ARBs or ACEIs this is lower than what had been reported [19], this might be due to the source of information in this study primarily depending on patients.…”
Section: Discussionsupporting
confidence: 87%
“…Our study shared similarities with previous Sudanese studies with regard to the mean age of HF patients, and that diabetes and hypertension were the main comorbid disease in HF [17,18]. On the other hands, 77% of patients were on Beta blockers, and 55.5% on ARBs or ACEIs this is lower than what had been reported [19], this might be due to the source of information in this study primarily depending on patients.…”
Section: Discussionsupporting
confidence: 87%
“…However, limited numbers of hospitalbased studies had been published. [4][5][6][7] For patients with HFrEF, defined by the ejection fraction (EF) ≤40%, morbidity, and mortality are reduced with target doses of key therapeutic medications such as: 1) Angiotensin-converting enzyme inhibitors (ACEIs), 2) Angiotensin receptor blockers (ARBs), 3) Angiotensin receptor-Neprilysin inhibitors (ARNi), 4) beta blockers (BBs), and 5) Mineralocorticoid receptor antagonist (MRA). According to guidelines, these medications should be initiated and up-titrated every two weeks to the target or maximal tolerated doses to achieve optimal outcomes.…”
Section: Introductionmentioning
confidence: 99%
“…23 A recent study conducted from Sudan found that the prevalence of HFpEF was 15%. 24 Another study reported from Ethiopia determined that HFis the third most common reason for admission to the medical wards of Saint Paul Medical College Hospital (SPMCH), accounting for 16% of all admissions. 25 In developed countries, the prevalence of HFpEF is increasing over time.…”
Section: Discussionmentioning
confidence: 99%